Mandate

Vinge advises Capman funds in connection with the sale of Proxima

May 05, 2011

Vinge has advised funds managed by CapMan in connection with the sale of Proxima. Proxima is a private healthcare provider conducting high quality primary care, diagnostics, specialist care, rehabilitation and occupational healthcare operations. The operations are primarily conducted in the Stockholm although the company also has centres in Uppsala, and the Östergötland and Skåne regions. The transaction is subject to approval by the competent competition authorities.

Vinge’s team consisted of partner Jan Byström together with, among others, associates Martin Hall, Anna-Sofia Nilsson Prevell, Malin Buch and project assistants Pernilla Warg and Mikaela Mars. Partner Marcus Glader provided competition law advice.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025